---
date: 2022-08-07
---

# COPD clinical trials

- related: [[COPD]], [[Pulmonology]]
- tags: #pulmonology
---

## Resting O2

- Lancet 1981
- resting O2 reduces mortality for pts with resting hypoxemia spO2<88
- LOTT trial 2016: no decrease in time to death or time to hospitalization

## Uplift

- UPLIFT 2008
- tiotopium relieves dyspnea, improves lung function, quality of life, reduces exacerbation
- no significant difference in FEV1 decline or mortality

## Torch

- TORCH 2007
- ICS/LABA improved lung function with FEV1 vs placebo vs LABA vs ICS
- no mortality benefit with combination therapy

## React

- REACT 2015
- triple therapy with Roflumulast (long acting PDE4 inhibitor)
- population: severe COPD, chronic bronchitis, and at least 2 exacerbations
- significant reduction in exacerbations
- increased side effects: diarrhea, nausea, decreased appetite

![](https://photos.thisispiggy.com/file/wikiFiles/20220807172033.png)

## Albert

- Albert 2011
- Chronic azithromycin
- population: pts with mod-severe COPD and either continuous O2 or at least on exacerbation in last year
-
